Avalon Ventures Xi, L.P. Janux Therapeutics, Inc. (JANX) insider trading activity

Avalon Ventures Xi, L.P. is of Janux Therapeutics, Inc.. Currently has a direct ownership of 2.07 Million shares of JANX, which is worth approximately $96.3 Million. The most recent transaction as insider was on Oct 18, 2024, when has been sold 660,018 shares (Common Stock) at a price of $48.74 per share, resulting in proceeds of $32,169,277. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.07M

36.67% 3M change

52.78% 12M change

Total Value Held $96.3 Million

Avalon Ventures XI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 18 2024	SELL Open market or private sale	$32,169,277 $48.74 p/Share	660,018 Reduced 24.16%	2,071,799 Common Stock
Oct 17 2024	SELL Open market or private sale	$92,186 $50.02 p/Share	1,843 Reduced 22.44%	6,371 Common Stock
Oct 17 2024	BUY Exercise of conversion of derivative security	$35,716 $20.19 p/Share	1,769 Added 17.72%	8,214 Common Stock
Oct 16 2024	SELL Open market or private sale	$5,067,725 $50.37 p/Share	100,610 Reduced 93.98%	6,445 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$212,297 $20.19 p/Share	10,515 Added 37.67%	17,402 Common Stock
Sep 30 2024	SELL Open market or private sale	$44,297 $46.24 p/Share	958 Reduced 12.21%	6,887 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	$18,554 $20.19 p/Share	919 Added 10.49%	7,845 Common Stock
Sep 27 2024	SELL Open market or private sale	$2,303,026 $46.78 p/Share	49,231 Reduced 87.67%	6,926 Common Stock
Sep 27 2024	BUY Exercise of conversion of derivative security	$35,372 $20.19 p/Share	1,752 Added 16.68%	8,752 Common Stock
Sep 26 2024	SELL Open market or private sale	$4,269,384 $47.28 p/Share	90,300 Reduced 3.05%	2,868,875 Common Stock
Sep 12 2024	SELL Open market or private sale	$7,427,457 $47.0 p/Share	158,031 Reduced 5.07%	2,959,175 Common Stock
Sep 10 2024	SELL Open market or private sale	$2,117,928 $46.4 p/Share	45,645 Reduced 1.44%	3,117,206 Common Stock
Sep 09 2024	SELL Open market or private sale	$92,364 $42.33 p/Share	2,182 Reduced 23.76%	7,000 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$42,378 $20.19 p/Share	2,099 Added 18.61%	9,182 Common Stock
Sep 06 2024	SELL Open market or private sale	$4,551,330 $42.0 p/Share	108,365 Reduced 3.31%	3,162,851 Common Stock
Jun 03 2024	SELL Open market or private sale	$37,081,025 $54.75 p/Share	677,279 Reduced 17.15%	3,271,216 Common Stock
Feb 29 2024	SELL Other acquisition or disposition	-	438,722 Reduced 10.0%	3,948,495 Common Stock
Jun 15 2021	BUY Conversion of derivative security	-	4,195,067 Added 48.88%	4,387,217 Common Stock

AVX

Avalon Ventures Xi, L.P.

La Jolla, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Value

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX

Account